Delivery Order SPE2DB22D3401-SPE2DB23FT1QP

Award Date 1/11/23
Potential Completion Date 1/12/23
Potential Value $13K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of SYNVISC-ONE SYRINGE 6ML to the Defense Logistics Agency (DLA), a defense agency. The $14,708.65 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on September 19, 2024, with a completion date of September 20, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award is a delivery order valued at $28,319.43 awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA). The contract covers the procurement of SYNVISC-ONE SYRINGE 6ML, a medical product, with a period of performance through July 29, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical...
This federal contract award is for the delivery of SYNVISC-ONE SYRINGE 6ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,332.59 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 3, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,188.89 firm fixed price delivery order is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a period of performance through March 11, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,164.74 firm fixed-price delivery order is for SYNVISC-ONE SYRINGE 6ML, a medical product, with a period of performance through March 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,910.00 Firm Fixed Price Delivery Order is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, to support federal healthcare programs. The contract has a performance period through July 26, 2024 and was not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of SYNVISC-ONE SYRINGE 6ML, a specialty medical product. The firm-fixed-price contract, valued at $3,503.46, has a period of performance through November 7, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of...
This federal contract award is for the delivery of SYNVISC-ONE syringes to the Defense Logistics Agency (DLA), a component of the Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 18, 2024, with a ceiling value of $18,591.58 and a completion date of December 19, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,773.68 firm fixed-price delivery order is for the supply of SYNVISC-ONE SYRINGE 6ML, a medical product, with a period of performance through February 5, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,965.57, is a delivery order for SYNVISC-ONE SYRINGE 6ML medical products. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB23FT1QP
    Delivery Order

This federal contract award is for the delivery of SYNVISC-ONE SYRINGE 6ML medical products to the Defense Logistics Agency (DLA). The $12,823.48 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., on January 11, 2023, with a completion date of January 12, 2023. The contract does not have a set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999.00, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000.00. These IDCs enable the company to efficiently provide a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, and other critical medical commodities, to support military, veterans', and other federal healthcare programs.

Generated 2/7/25, 9:10 AM